Renibus Therapeutics has announced two hires to its leadership team, including Bhupinder Singh as chief medical officer and Jamie Donadio as chief financial officer. Both will report to Frank Stonebanks, chairman and CEO of Renibus.
Singh previously was a founder of the Southwest Kidney Institute, and also worked at ZS Pharma, where he led the clinical development of the hyperkalemia treatment, LOKELMA.
Before joining Renibus, Donadio was CFO at BioTheryX, as well as CFO at Mirati Therapeutics. He also held the role of senior director of finance at Amylin Pharmaceuticals.
